The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
The promise of minocycline in neurology
Abstract
The capacity of minocycline to alleviate disease for several neurological disorders in animals is increasingly being recognised. Indeed, that one drug alone can attenuate the severity of disease in stroke, multiple sclerosis, spinal-cord injury, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis is astounding. In this review, we describe the evidence for the efficacy of minocycline in several animal models of neurological disease, discuss the mechanisms by which minocycline affects a range of neurological diseases with diverse causes, and introduce the emerging investigation of minocycline in clinical neurology. The encouraging results of minocycline in experimental neurology bode well for its therapeutic use in human neurological diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thanks to the ability to efficiently cross the BBB, minocycline is considered neuroprotective for a variety of neurological conditions, including PD [251,252,253,254,255,256,257].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [253]
In the citing paper
“Thanks to the ability to efficiently cross the BBB, minocycline is considered neuroprotective for a variety of neurological conditions, including PD [251,252,253,254,255,256,257].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [253]
Citations
Cites
Inflammation is detrimental for neurogenesis in adult brain
Ekdahl, C. T., Claasen, J.-H., Bonde, S., Kokaia, Z., & Lindvall, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234031100 · Cited by 1,559
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Metalloproteinases in biology and pathology of the nervous system
Yong, W. V., Power, C., Forsyth, P., & Edwards, D. (2001) · Nature Reviews Neuroscience · doi:10.1038/35081571 · Cited by 1,094
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V. O., Li, M., Sarang, S. S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,069
Chen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Hersch, S. M., et al. (2000) · Nature Medicine · doi:10.1038/77528 · Cited by 1,060
Yrjänheikki, J., Kauppinen, T. M., Keinänen, R., Goldsteins, G., Chan, P. H., & Koıstınaho, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13496 · Cited by 1,040
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958
Du, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789
Chen, D., Endres, R. L., Erickson, C. A., Weis, K. F., McGregor, M. W., Kawaoka, Y., & Payne, L. G. (2000) · Nature Medicine · doi:10.1038/80538 · Cited by 547
Research works printed but not linked: 1
- Giuliani, 2004, Synergistic activity of minocycline and glatiramer acetate in an animal model of multiple sclerosis, Mult Scler, 9, S76
Cited by
Sorted by citations
Items 301–400 of 523
Minocycline Inhibits ICAD Degradation and the NF-ΚB Activation Induced by 6-OHDA in PC12 Cells
Jiang, B.-P., Le, L., Xu, L.-J., & Xiao, P.-G. (2014) · Brain Research · doi:10.1016/j.brainres.2014.08.001 · Cited by 19
Qaid, E. Y. A., Abdullah, Z., Zakaria, R., & Long, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113474 · Cited by 18
Chen, X., Pi, R., Liu, M., Ma, X., Jiang, Y., Liu, Y., Mao, X., & Hu, X. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.039 · Cited by 20
Stress-Induced NLRP3 Inflammasome in Human Diseases
Alcocer‐Gómez, E., Castejón‐Vega, B., & Cordero, M. D. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.02.002 · Cited by 19
Afshary, K., Chamanara, M., Talari, B., Rezaei, P., & Nassireslami, E. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01509-8 · Cited by 20
Zhang, G., Zha, J., Liu, J., & Di, J. (2018) · Archives of Medical Science · doi:10.5114/aoms.2018.73520 · Cited by 20
Ciapała, K., & Mika, J. (2023) · Pharmaceuticals · doi:10.3390/ph16111624 · Cited by 20
The efficacy of minocycline against methotrexate-induced pulmonary fibrosis in mice.
Kalemci, S., Dirican, N., Çetin, E. S., Sözen, H., Üner, A. G., Yaylalı, A., Aksun, S., Karaçam, V., Ulger, E., Sütçü, R., et al. (2013) · PubMed · Cited by 19
Apoorv, T. S., & Babu, P. P. (2016) · Cytokine · doi:10.1016/j.cyto.2016.11.001 · Cited by 19
Afshari, K., Dehdashtian, A., Haddad, N.-S., Jazaeri, S. Z., Ursu, D. C., Khalilzadeh, M., Haj‐Mirzaian, A., Shakiba, S., Burns, T. C., Tavangar, S. M., et al. (2020) · Neurological Research · doi:10.1080/01616412.2020.1819090 · Cited by 19
Zhang, J., Boska, M. D., Zheng, Y., Liu, J., Fox, H. S., & Xiong, H. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02142-x · Cited by 19
Liu, F., WU, A.-H., Zhou, S.-J., Deng, Y.-L., Zhang, Z.-Y., Zhang, E.-L., & Huang, Z. (2014) · Oncology Reports · doi:10.3892/or.2014.3248 · Cited by 19
Hou, Y., Ryu, C. H., Jun, J. A., Kim, S. M., Jeong, C. H., & Jeun, S. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.06.001 · Cited by 19
Bilirubin-induced neurological damage
Gazzin, S., & Tiribelli, C. (2011) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2011.607590 · Cited by 19
Sakata, H., Fujimura, M., Mugikura, S., Sato, K., & Tominaga, T. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2015.03.050 · Cited by 19
Zaprinast diminished pain and enhanced opioid analgesia in a rat neuropathic pain model
Rojewska, E., Piotrowska, A., Jurga, A. M., Makuch, W., & Mika, J. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.09.001 · Cited by 18
The Effect of Minocycline on Fat Graft Survival and Apoptotic Pathway
Güney, K., Özel, B., Seymen, C. M., Elmas, Ç., Tuncer, S., Çenetoğlu, S., & Tatar, S. (2019) · Facial Plastic Surgery · doi:10.1055/s-0039-1677709 · Cited by 18
Ruíz‐Antorán, B., Sancho‐López, A., Cazorla-Calleja, R., López-Pájaro, L. F., Leiva, Á., Escalera, G. I., Marín-Serrano, M. E., Rincón-Ortega, M., Herguedas, J. L., Rossignoli-Palomeque, T., et al. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0891-6 · Cited by 18
Gazzin, S., Ben, M. D., Montrone, M., Jayanti, S. D., Lorenzon, A., Bramante, A., Bottin, C., Moretti, R., & Tiribelli, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010299 · Cited by 18
Flow-augmentation bypass for moyamoya disease
Fujimura, M., & Tominaga, T. (2021) · Journal of Neurosurgical Sciences · doi:10.23736/s0390-5616.20.05079-1 · Cited by 17
Blue Light Induces RPE Cell Necroptosis, Which Can Be Inhibited by Minocycline
Song, W., Zhu, R., Gao, W., Chen, X., & Yang, L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.831463 · Cited by 17
Poggini, S., Banqueri, M., Albanese, N. C., Golia, M. T., Ibáñez, F. G., Limatola, C., Fuhrmann, M., Lalowski, M. M., Tremblay, M., Maggi, L., et al. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114295 · Cited by 18
Inhibition of brain retinoic acid catabolism: a mechanism for minocycline's pleiotropic actions?
Regen, F., Bret, N. L., Hildebrand, M., Herzog, I., Heuser, I., & Hellmann‐Regen, J. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1036116 · Cited by 20
Tao, T., Feng, J., Xu, G., Fu, J., Li, X., & Qin, X. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0374-z · Cited by 17
Min, S. H., Lee, S. H., Shim, H., Park, J., Lee, Y. I., Kim, H., & Hyun, J. K. (2010) · Spine · doi:10.1097/brs.0b013e3181d8b92a · Cited by 16
Minocycline promotes the generation of dendritic cells with regulatory properties
Kim, N., Park, C., Im, S., Kim, J.-W., Lee, J., Park, Y.-J., Song, S., & Lee, C. (2016) · Oncotarget · doi:10.18632/oncotarget.10810 · Cited by 16
Minocycline attenuates interferon-α-induced impairments in rat fear extinction
Bi, Q., Shi, L., Yang, P., Wang, J., & Qin, L. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0638-z · Cited by 18
Minocycline exerts acute inhibitory effects on cerebral cortex excitability in humans
Lang, N., Rothkegel, H., Terney, D., Antal, A., & Paulus, W. (2013) · Epilepsy Research · doi:10.1016/j.eplepsyres.2013.09.006 · Cited by 15
Tuan, L., Yeh, J.-W., Lee, L. J., & Lee, L. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03258-2 · Cited by 17
Current Advances in Japanese Encephalitis Virus Drug Development
Guo, J., Mi, Y., Guo, Y. Q., Bai, Y., Wang, M., Wang, W., & Wang, Y. (2024) · Viruses · doi:10.3390/v16020202 · Cited by 15
Migliorini, F., Pilone, M., Eschweiler, J., Katusić, D., Memminger, M. K., & Maffulli, N. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2470326 · Cited by 15
Neuroprotective effect of minocycline on rat retinal ischemia-reperfusion injury.
Li, X., Ye, Z., Pei, S., Zheng, D., & Zhu, L. (2021) · PubMed Central · Cited by 15
Zheng, F., von Spreckelsen, N., Zhang, X., Stavrinou, P. C., Timmer, M., Dohmen, C., Goldbrunner, R., Cao, F., Zhang, Q., Ran, Q., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186607 · Cited by 15
The trials and errors in MS therapy.
Kleinschnitz, C., Meuth, S. G., & Wiendl, H. (2008) · PubMed · Cited by 15
Intestinal injury and changes of the gut microbiota after ischemic stroke
Shen, Y., Wang, J. A., Li, Y., Kang, X., & Gu, L. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1557746 · Cited by 15
Miwa, K. (2021) · Internal Medicine · doi:10.2169/internalmedicine.6082-20 · Cited by 14
Immunological Biomarkers as Predictors of Treatment Response in Psychotic Disorders
Orbe, E. B., & Benros, M. E. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13091382 · Cited by 17
de Souza, C. C., da Silva, M. C., Afonso, R. T. L., Cardoso, M. M., de Souza, L. L., Santos, A. G., Santos, I. R., Franco, E. C. S., & Gomes‐Leal, W. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1976191 · Cited by 14
CASP-9: A susceptibility locus for multiple sclerosis in Italy
Andreoli, V., Trecroci, F., Russa, A. L., Valentino, P., Condino, F., Latorre, V., Nisticò, R., Pirritano, D., Giudice, F. D., Canino, M., et al. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.03.013 · Cited by 13
Omidvari, S., Azimzadeh, Z., Rashnoo, F., Tahmasebinia, F., Keramatinia, A., Roozbahany, N. A., Abbaszadeh, H., & Darabi, S. (2023) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2023-2488 · Cited by 15
Minocycline‐induced dermatomyositis
Geddes, M. R., Sinnreich, M., & Chalk, C. (2010) · Muscle & Nerve · doi:10.1002/mus.21487 · Cited by 13
Striking Growth-inhibitory Effects of Minocycline on Human Prostate Cancer Cell Lines
Regen, F., Heuser, I., Herzog, I., & Hellmann‐Regen, J. (2013) · Urology · doi:10.1016/j.urology.2013.10.029 · Cited by 13
Lim, J. J., & Hyun, S. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112803 · Cited by 16
Peng, H., Ma, L., Lv, M.-H., Hu, T., & Liu, T. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.01.047 · Cited by 13
Lan, A., Xu, W., Zhao, J., Li, C., Qi, M., Li, X., Wang, L., & Zhou, Y. (2018) · BioMedical Engineering OnLine · doi:10.1186/s12938-018-0520-6 · Cited by 13
Orsucci, D., Mancuso, M., & Siciliano, G. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.152819 · Cited by 13
Strategies for regenerating injured axons after spinal cord injury – insights from brain development
Yamashita, T. (2008) · Biologics · doi:10.2147/btt.s2715 · Cited by 13
Immunomodulatory drug treatment in multiple sclerosis
Aharoni, R. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.117 · Cited by 13
Samour, M. S., Nagi, S. S., Shortland, P. J., & Mahns, D. A. (2017) · Journal of Pain · doi:10.1016/j.jpain.2017.03.009 · Cited by 12
Chen, X., Chen, S., Jiang, Y., Zhu, C., Wu, A., Ma, X., Peng, F., Ma, L., Zhu, D., Wang, Q., et al. (2012) · Neurological Sciences · doi:10.1007/s10072-012-1246-z · Cited by 12
Amin, B., Hajhashemi, V., & Hosseinzadeh, H. (2015) · Europe PMC (PubMed Central) · Cited by 12
Herrmann, I., Kellert, M., Spreer, A., Gerber, J., Eiffert, H., Prinz, M., & Nau, R. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl446 · Cited by 12
Yun, H. M., Noh, S., & Hyun, S. (2017) · Scientific Reports · doi:10.1038/srep44724 · Cited by 11
Capadona, J. R. (2018) · Journal of Immunological Sciences · doi:10.29245/2578-3009/2018/4.1157 · Cited by 11
Mechanisms of multiple sclerosis
Lassmann, H. (2005) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2005.11.007 · Cited by 14
Simple Liquid Chromatographic Determination of Minocycline in Brain and Plasma
Milane, A., Fernandez, C., Bensimon, G., Meininger, V., & Farinotti, R. (2007) · Chromatographia · doi:10.1365/s10337-006-0167-5 · Cited by 11
Vecchiarelli, H. A., Lopes, L. T., Paolicelli, R. C., Stevens, B., Wake, H., & Tremblay, M. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_11 · Cited by 10
Dunn, J. S., Nagi, S. S., & Mahns, D. A. (2020) · European Journal of Pain · doi:10.1002/ejp.1558 · Cited by 10
Yang, X., Li, T., Liu, J., Sun, H. B., Cheng, L., Song, X., Han, Z., Luo, H., Han, W., Xie, L., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14352 · Cited by 10
Li, K., Fu, K., Light, A. R., & Mao, J. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.02.003 · Cited by 10
Using magnetic resonance imaging in animal models to guide drug development in multiple sclerosis
Nathoo, N., Yong, V. W., & Dunn, J. F. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513512709 · Cited by 10
Arezoomandan, R., Riahi, E., & Haghparast, A. (2017) · Addiction Biology · doi:10.1111/adb.12557 · Cited by 10
Kitamura, Y., Hongo, S., Yamashita, Y., Yagi, S., Otsuki, K., Miki, A., Okada, A., Ushio, S., Esumi, S., & Sendo, T. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.10.049 · Cited by 12
Alavi, S., Darharaj, M., Bilehsavar, S. H., Amini, M., Zafarghandi, M. B. S., Berenji, V., & Arezoomandan, R. (2021) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000460 · Cited by 10
The Role of Concomitant Nrf2 Targeting and Stem Cell Therapy in Cerebrovascular Disease
Gordon, J., Lockard, G., Monsour, M., Alayli, A., & Borlongan, C. V. (2022) · Antioxidants · doi:10.3390/antiox11081447 · Cited by 11
Is minocycline useful for therapy of acute viral encephalitis?
Jackson, A. C. (2012) · Antiviral Research · doi:10.1016/j.antiviral.2012.06.005 · Cited by 10
Minocycline for axonal regeneration after nerve injury: A double-edged sword
Casha, S., Yong, V. W., & Midha, R. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.06.016 · Cited by 10
Gámez, J. (2008) · PubMed · Cited by 10
Novel therapeutic modulators of astrocytes for hydrocephalus
Yang, Y., Wang, C., Chen, R., Wang, Y.-C., Tan, C., Liu, J., Zhang, Q., & Xiao, G. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.932955 · Cited by 10
Iglesias, L. P., Soares, N., Asth, L., Moreira, F. A., & de Aguiar, D. C. (2023) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000754 · Cited by 8
Nishiguchi, T., Yamanishi, K., Patel, S. S., Malicoat, J. R., Phuong, N. J., Seki, T., Ishii, T., Aoyama, B., Shimura, A., Gorantla, N., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03130-4 · Cited by 9
Bumetanide prevents diazepam-modified anxiety-like behavior in lipopolysaccharide-treated mice
Matsumoto, D., Ushio, S., Wada, Y., Noda, Y., Esumi, S., Izushi, Y., Kitamura, Y., & Sendo, T. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174195 · Cited by 12
Recombinant Human Prion Protein Fragment 90–231, a Useful Model to Study Prion Neurotoxicity
Corsaro, A., Thellung, S., Villa, V., Nizzari, M., Aceto, A., & Florio, T. (2012) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2011.0038 · Cited by 9
Immune Modulatory Treatments for Autism Spectrum Disorder
Thom, R. P., & McDougle, C. J. (2020) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2020.100836 · Cited by 9
Update on huntington’s disease
Berman, S. B., & Greenamyre, J. T. (2006) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-006-0019-6 · Cited by 9
Managing Overly Rapid Correction of Chronic Hyponatremia
Kamel, K. S., & Halperin, M. L. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010101062 · Cited by 9
Is it possible to prevent excessive synaptic pruning in schizophrenia? Possibilities and limitations
Pawlak, A., Stefanowicz, J., Kotkowska, Z., Gabryelska, A., Sochal, M., Napieraj, F., Kotlicka‐Antczak, M., & Strzelecki, D. (2025) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2025.1656232 · Cited by 9
The role of MMPs in intracerebral hemorrhage
Guan, X., Li, M., Li, H., Guo, Z., Ullah, M. S., Liu, X., Wu, M., & Yu, W. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1667228 · Cited by 8
Meshkini, A., Ohadi, M. A. D., Mirghaderi, P., Mirzaei, F., Rafiei, E., Allahyari, N., Namvar, M., & Iranmehr, A. (2023) · Interdisciplinary Neurosurgery · doi:10.1016/j.inat.2023.101883 · Cited by 8
Planas, A. M. (2013) · Stroke · doi:10.1161/strokeaha.111.000495 · Cited by 8
Minocycline encapsulated chitosan nanoparticles for central antinociceptive activity
Nagpal, K., Singh, S. K., & Mishra, D. N. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.07.055 · Cited by 8
Antibiotics with therapeutic effects on spinal cord injury: a review
Afshari, K., Roudsari, N. M., Lashgari, N., Haddadi, N., Haj‐Mirzaian, A., Nejad, M. H., Shafaroodi, H., Ghasemi, M., Dehpour, A. R., & Abdolghaffari, A. H. (2020) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12605 · Cited by 10
Management of Intracerebral Hemorrhage In 2020
Blacker, D., & Musuka, T. D. (2011) · Future Neurology · doi:10.2217/fnl.11.49 · Cited by 7
Hao, X., Ye, F., Holste, K. G., Hua, Y., Garton, H. J. L., Keep, R. F., & Xi, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042306 · Cited by 8
Minocycline for Schizophrenia: A critical review
Miyaoka, T. (2012) · Open Journal of Psychiatry · doi:10.4236/ojpsych.2012.224056 · Cited by 8
Shin, H. S., Zouboulis, C. C., Kim, M., Lee, D. H., & Chung, J. H. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18079 · Cited by 7
Lu, Y., Guan, L., Zhang, M., Yang, Q., Qiu, B., Zhou, D., Wang, Y., Pan, Y., Wang, L., Zhou, X., et al. (2025) · Stroke and Vascular Neurology · doi:10.1136/svn-2024-003577 · Cited by 7
Pourkhodadad, S., Oryan, S., Hadipour, M. M., Kaka, G., & Sadraie, S. H. (2021) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.2021.1727.1 · Cited by 7
Ahuja, C. S., Cadotte, D. W., & Fehlings, M. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-43140-8.00033-0 · Cited by 5
Hour, M., Liu, W.-T., Lu, I., Kuo, S., & Gean, P. (2014) · Europe PMC (PubMed Central) · Cited by 7
Evaluation of the Neuroprotective Effect of Minocycline in a Rabbit Spinal Cord Ischemia Model
Watanabe, K., Kawaguchi, M., Kitagawa, K., Inoue, S., Konishi, N., & Furuya, H. (2012) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2012.05.003 · Cited by 7
Bulduk, E. B., Kurt, G., Barun, S., Aydemir, Ö., Kiziltas, M., Öktem, M., Turhan, T., & Atilla, P. (2018) · Turkish Neurosurgery · doi:10.5137/1019-5149.jtn.22744-18.1 · Cited by 7
Minocycline in neurological diseases
Bandini, F. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)00998-1 · Cited by 7
Human rabies therapy: lessons learned from experimental studies in mouse models.
Jackson, A. C., Scott, C. A., Owen, J., Weli, S. C., & Rossiter, J. P. (2008) · PubMed · Cited by 7
Shamsi, F., Zeraatpisheh, Z., Alipour, H., Nazari, A., & Aligholi, H. (2019) · International Journal of Neuroscience · doi:10.1080/00207454.2019.1699083 · Cited by 6
Wang, B., Lin, W., & Zhu, H. (2021) · European Journal of Inflammation · doi:10.1177/20587392211010898 · Cited by 6
Minocycline Directly Enhances the Self-Renewal of Adult Neural Precursor Cells
Kuroda, A., Fuchigami, T., Fuke, S., Koyama, N., Ikenaka, K., & Hitoshi, S. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2422-6 · Cited by 6
Minocycline Ameliorates Neuronal Loss after Pilocarpine-Induced Status epilepticus
Arisi, G. M., Foresti, M. L., Montañez, A., & Shapiro, L. A. (2014) · doi:10.13140/2.1.2071.1367 · Cited by 6
MMP–2 and MMP–9—Investigations in Neuropathic Pain Phases
Ji, R., Xu, Z., Wang, X., & Lo, E. H. (2008) · touchREVIEWS in Neurology · doi:10.17925/usn.2008.04.02.71 · Cited by 6
Targeting Mammalian Translational Inhibition with Tetracyclines
Boer, R. E., & Schneekloth, J. S. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.12.006 · Cited by 6
Metadata
- Authors
- Yong, V. W., Wells, J., Giuliani, F., Casha, S., Power, C., & Metz, L. M.
- Affiliations
- University of Calgary (CA)
- Corresponding author
- Yong, V Wee
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2004-12
- Volume
- 3
- Issue
- 12
- Pages
- 744-751
- ISSN
- 1474-4422 (ISSN-L)
- OpenAlex
- W2063885093
- Cited by
- 518
- References
- 64
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 17 · 2023: 19 · 2022: 20 · 2021: 19 · 2020: 24 · 2019: 14 · 2018: 27 · 2017: 19 · 2016: 17 · 2015: 28 · 2014: 33 · 2013: 32 · 2012: 35
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Teva Pharmaceutical Industries
- Multiple Sclerosis Society of Canada
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- minocycline, neuroprotection, stroke, multiple sclerosis, spinal cord injury, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, animal models of neurological disease, clinical trials
- MeSH terms
- Animals, Humans, Minocycline, Nervous System Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review